Silexion Therapeutics Corp
SLXN· Nasdaq
SLXNSilexion Therapeutics Corp
Filed Mar 18, 2025 · 10-K · 77 days after period end · 0001178913-25-000887
derived · Computed from the longer spans the company filed.
no prior Q4 2023 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2024 · filed Mar 18, 2025 · 77 d after period end
Silexion Therapeutics Corp · CIK 2022416 · Engraved from SEC EDGAR
